Saturday, February 20, 2021 11:34:20 AM
Too many red flags here. And it's not just the fact that these guys have been known to pump and dump for years at the expense of shareholders with dilution upon dilution and Kal insider trading. Execs paying themselves monster salaries with NO revenues. There's other reasons. I have been around pharma for long enough to recognize them.
Delays upon delays. Starting a new research program before the last open trial hasn't released data yet. Classic move. Pump up the SP before dropping the bad news. CSO working on another company. Increasing the number of individuals in the preliminary trial results that flopped, in an effort to improve the statistical power to search for signal.
Good luck to this who plan to hold through news. All the signs are pointing to a big flop coming.
Invest in the science.
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM